Khajik Yaqob
Kurdistan Pediatric Society, Iraq
Biography
Abstract
Background Cerebral palsy is a common pediatric problem encountered in about 1:3 per 1000 born children and causing variable mental, motor and behavioral s dilemmas. Newly introduced trials of neurogenesis with different agents are now extensively evaluated. Objective our study was conducted to evaluate the neurotrophic response to B12 vitamin and omega-3 fatty acids in children diagnosed early with variable forms of cerebral palsy. The response was monitored both clinically and with C.T Scan as being a highly predictive tool for assessing cerebral palsy. Design The study was carried out on 40 cerebral palsy pa1ents; 26 (65%) out of them were girls, and 14 of them were boys, aged from 0 to 5 years old; from outpa1ent clinic at Zakho/Duhok General Hospital in Kurdistan Region-Iraq. Patients were treated and followed
Up to 6 months to one year. They were represented and adjusted by full history taking and clinical examination. Brain C.T scans were done for every patient to assess the degree of brain atrophy before starting this combined therapy, and every month for six months to one year. There was an improvement in general health of children after interventional therapy. Results The study revealed that early interven1on of both omega 3 and B12 vitamin in children under 5 with cerebral palsy (cp) shows great response based on clinical examination and CT
scan findings. Almost, after combined therapy, 80% of children with delayed speech delay have very good response and improvement, 77% of children with delayed milestone and hypertonia, and 87% with delayed walking have posi1ve clinical outcomes. Both sexes have equal response to combined therapy. Such findings were obtained as a result of early treatment and diagnosis of children with (CP). In addition, among the treated children with CP, improvement in CT scan results was obtained. 84% of treated children have great improvement in their neuroimaging results from moderate/severe forms of brain atrophy to A mild form of brain atrophy after being treated and followed up for 6 months- 1 year.
Conclusions
The damaged brain sites based on CT scan results, showed progressive improvement in response to B12 and omega-3 fa?y acids upon daily supplement throughout 6 months to one year. However, combining these 2 drugs showed preservative synergistic consequences. B12 vitamin and omega- 3 faty acids are valuable therapy for children with various forms of cerebral palsy particularly when being linked. The greatest improvement in speech and motor development was significantly observed in about 32 patients (80%) of treated children with B12 vitamin and omega- 3 faty acids. Others have less response to combine therapy as being presented and diagnosed beyond 1 year of age (16%) Key words: Cerebral palsy, early intervention, B12 and omega 3, Brain, Motor and speech development, C.T Scan and clinical improvement, outpatient clinic